USU Biochemists Report Further Findings on Targeting Cancer-Specific Mutations With CRISPR (opens in new tab)

On the heels of breakthrough findings about a lesser-known CRISPR bacterial immune system and its potential for battling cancer, Utah State University biochemists Ryan Jackson and Kadin Crosby report further discoveries about emerging targeted cell-killing technology. “Our knowledge of CRISPR and its potential for advancing cancer treatments is progressing rapidly,” says Jackson, in USU’s . “Our collaborative efforts with scientists around the world are accelerating efforts to understand thes...